Introduction
Toxic epidermal necrolysis (TEN) is a rare cutaneous adverse drug reaction, with a mortality of around 30% [1] . Prior drug intake is reported in over 95% of patients with TEN, and a strong association is observed in 80% of cases [2, 3] . Other, rarer causes include infections and immunizations. To date, more than 100 drugs have been associated with the development of TEN, the most frequent being allopurinol, antibiotics, nonsteroidal anti-inflammatory drugs and anticonvulsants [3] . Self-medication with phytotherapeutics has become increasingly popular, and due to their availability, their abusive use is increasing. We describe a patient with TEN most likely triggered by the regular use of the herb fenugreek.
Case Report
A 32-year-old female presented to a regional hospital with fever, headache and beginning exanthema. She had given birth to her second child, without any complications, 1 month prior to admission. The patient's medical history included the irregular intake of metamizole, paracetamol (acetaminophen) and ibuprofen since giving birth. Additionally, she regularly took a herbal preparation made of pure fenugreek seeds to improve lactation. All medications except for fenugreek had been taken by the patient during her previous pregnancy without the appearance of any adverse reactions. The patient was first diagnosed with a common cold and sent back home. Due to the deterioration of her general condition with spreading exanthema on the face and upper trunk, the patient was transferred to the University Hospital with the suspected diagnosis of severe cutaneous adverse drug reaction. On admission, she presented with multiple bullae and erosions with a positive Nikolsky sign and skin sloughing involving approximately 30-40% of her body surface including the mouth, lips and tongue ( fig. 1 ). There was no involvement of the eyes, genital mucosa or other mucosal areas. Two biopsies were performed, and both confirmed the diagnosis of TEN with completely necrotic epidermis with mixed-cell inflammatory infiltrates in the histological sections. The severity-of-illness score (SCORTEN) was 2, with a predicted mortality of 3% [4, 5] . Treatment with intravenous high-dosed immunoglobulins (IVIg) at a total dose of 3 g/kg body weight was initiated and continued over the following 3 days together with supportive treatment at the intensive care unit. In the following days, the patient's condition markedly improved, and she was finally discharged 2 weeks later after full recovery. In order to identify the causative agent, an allergologic workup was performed 4 months after full recovery. Lymphocyte transformation tests (LTT) demonstrated a significant sensitiBentele-Jaberg et al. ( table 1 ) . However, it should be noted that the LTT are not a standardized procedure and merely demonstrate the proliferation of lymphocytes in the presence of various compounds. Skin patch tests were not performed because the rate of positive test reactions in Stevens-Johnson syndrome (SJS)/TEN is rather low with 24% [6] . Due to the risk of severe side effects after TEN, we did not apply oral provocation tests. Based on the LTT, fenugreek was identified as the most likely causative agent, despite the fact that infectious agents (e.g. certain viruses) cannot be ruled out completely as causative agents or cofactors of TEN. As drug hypersensitivity to metamizole, paracetamol and ibuprofen cannot be excluded without provocation testing, we advised against the intake of all three pain killers as well as of fenugreek in the future.
Discussion
Today, SJS and TEN are regarded as being different manifestations in degrees of severity of one and the same rare, acute and life-threatening mucocutaneous disease, which is nearly always drug related [1] . In this context, TEN represents the severest form of this pathological entity. TEN is a consequence of extensive keratinocyte cell death that results in the separation of significant areas of skin at the dermal-epidermal junction, producing the appearance of scalded skin. This massive cell death results in mucous membrane detachment and contributes to the characteristic symptoms of TEN, which include high fever, skin pain, anxiety and asthenia [1] . In terms of pathogenesis, TEN is thought to be the consequence of an altered immune response to an antigenic drug-tissue complex, although the exact pathophysiologic mechanism(s) are still unclear. Today, three different concepts on how the antigenic drug-tissue complex is formed exist [7] : (a) covalent binding of a drug to a cellular peptide (hapten/prohapten concept), (b) noncovalent, direct interaction of a drug with a specific major histocompatibility complex (MHC) I allotype (p-i concept), and (c) presentation of an alteredself repertoire by direct drug-MHC I interaction (altered peptide concept). Whereas the well-known hapten model is less likely to be human leukocyte antigen (HLA) re- Color version available online 101 stricted, the other two concepts favor specific HLA phenotypes [8] [9] [10] . In line with the concepts of HLA-restricted drug presentation are reports on the genetic susceptibility, as evidenced by the identification of specific drug-related HLA alleles as major susceptibility genes for the development of SJS and TEN [11] [12] [13] . However, it should be noted that most HLA phenotypes associated with SJS/TEN are of relevance for people of Han-Chinese or South East Asian ancestry only. As a result of immune activation by the drug-tissue complex, an interplay of various cell types and cytokines (yet to be defined) is initiated that is accompanied by a strong expression of the cytolytic molecule FasL on keratinocytes as well as granulysin and annexin A1 secretion from cytotoxic T lymphocytes, natural killer cells, natural killer T cells and monocytes [14] [15] [16] [17] [18] [19] . This leads to FasL-and granulysin-mediated apoptosis and/or annexin-dependent necroptosis of keratinocytes and subsequent epidermal necrosis and detachment. Of note, granulysin is expressed at high concentrations in the blister fluid of TEN patients, suggesting an important role of this protein in the pathogenesis of TEN [17] .
To date, no specific therapies for TEN have shown efficacy in prospective, controlled clinical trials. Case reports and case series have reported the use of cyclosporine, cyclophosphamide, plasmapheresis, N-acetylcysteine, tumor necrosis factor-α antagonists (e.g. etanercept, infliximab), systemic corticosteroids and thalidomide [for a review, see 1 ]. In our case, we treated the patient with high-dose IVIg (>2 g/kg bodyweight total). Even though the mechanism of action is still unclear, with confirmed diagnosis as well as for severe TEN, early administration of high-dose IVIg may be considered [1, 20] . Interestingly, it has been shown that IVIg do not reduce the levels of granulysin. This might be, at least, partly responsible for the lack of efficacy of IVIg in some patients [21, 22] . Alternatively, a recent study has shown excellent efficacy of cyclosporine in the treatment of TEN [23, 24] .
Although TEN is mostly caused by prescribed drugs, we report the first case of TEN due to fenugreek. Fenugreek belongs to the family of Fabaceae and is used as a herb (dried or fresh leaves), spice (seeds) and vegetable (fresh leaves) in the Indian subcontinent, Argentina, Egypt, France, Spain and Turkey. Fenugreek is a popular phytotherapeutic and is thought to have beneficial effects in multiple sclerosis, diabetes, cancer and lactation although its mode of action is unknown, and controlled clinical trials are missing. Fenugreek seeds consist of approximately 50% fiber (fenugreekine), 20% gums, 20% proteins, besides moisture, lipids, starch and ash. Additionally, chemical analyses have identified alkaloids and various sapogenins as part of fenugreek seeds. The antigenic parts of fenugreek are still unknown, but specific IgE binding with the fenugreek proteins in immunoblotting has been reported in 2 patients allergic to fenugreek and in mice sensitized to fenugreek [25, 26] . Not much is known about the adverse cutaneous side effects of fenugreek intake. A prospective observational study conducted in Bangladesh analyzed a total of 29 patients with TEN admitted to the intensive care unit [27] . In 10 patients (34%), the causative agent remains unidentified. However, those patients had treated themselves with several traditional herbal drugs to cure fever before the onset of TEN. Those herbal mixtures included Ocimum, Tribulus, Caesalpinia, Tinospora, Piper, Cichorium and Foeniculum . As Caesalpinia and fenugreek belong to the same plant family, namely Fabaceae, one can speculate that severe cutaneous adverse reactions were indeed triggered by herbal mixture in certain of those patients. The family of Fabaceae includes edible leguminous plants (e.g. beans, soya beans, lentils and peanuts). Because cross-reactivity between certain leguminous plants is known in allergic patients, one has to consider the possibility of food allergy to leguminous plants in the patient's allergological workup. However, as she had eaten beans, soya beans, lentils and peanuts in the meantime without any complications, secondary food allergy to legumes could be ruled out. We performed a thorough literature search on phytotherapeutics as triggers of SJS and TEN. We identified 4 case reports and 1 cohort study including 10 patients [27] [28] [29] [30] [31] . In those reports, SJS and TEN were described to be caused by the intake of traditional medications (Chinese roots and drinks), herbal ointment containing realgar and ayurvedic drugs ( table 2 ) [27] [28] [29] [30] [31] . In an additional study utilizing large pharmacovigilance data in Thailand from 2002 102 to 2013, the authors computed that 0.001% of all reported serious adverse drug reactions were due to Thai traditional medicine. Of those, green traditional medicine was associated with an increased odds ratio in terms of SJS [32] . Taken together, it is important to consider herbal medication as a possible trigger of severe cutaneous adverse reactions like SJS and TEN as phytotherapeutics are becoming more popular in industrialized countries and are easily available.
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